Boxborough, Massachusetts — According to state and local economic development sources Arranta Bio plans to invest $150,000,000.00 to build out 130,000 square feet of new space in Boxborough. The company plans to occupy the new space in Boxborough, on or about April 1, 2022. According to the company website Since 2009, we have been developing processes and gaining unparalleled experience with live biotherapeutic products (LBPs), so that today Arranta Bio is delivering on its vision to be the leading, best-in-class microbiome contract development and manufacturing organization (CDMO). Arranta is more than a CDMO; we are a strategic partner, teaming up with innovators, aligning ourselves with their vision to unlock the potential of the microbiome, and bringing their therapies from lab to market. We support early clinical supply through to commercial manufacturing with an unparalleled commitment to build and operate the capacity needed to support this sector. Whether you are just starting out or encountering challenges unlocking the potential of your product, Arranta has the scientific expertise to bring your LBP products to life.

To learn more about Arranta Bio, visit http://arrantabio.com/

Company Contact:
Mark Bamforth, Chief Executive Officer
https://www.linkedin.com/in/mark-bamforth-b1001410/
785-760-3128

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved